Risk factors associated with hypophosphatemia in chronic Hepatitis B patients treated with tenofovir disoproxil fumarate. - Abstract - Europe PMC

Europe PMC is an archive of life sciences journal literature.

Risk factors associated with hypophosphatemia in chronic Hepatitis

Asian-Pacific clinical practice guidelines on the management of

KASL clinical practice guidelines for management of chronic

Maternal and infant renal safety following tenofovir disoproxil

Treatment with β-blocker nebivolol ameliorates oxidative stress

PDF) Comparable efficacy of tenofovir versus entecavir and

Treatment with β-blocker nebivolol ameliorates oxidative stress

Switching to tenofovir disoproxil fumarate in entecavir‑treated

Risk factors associated with hypophosphatemia in chronic Hepatitis

An expert consensus for the management of chronic hepatitis B in

Switching from tenofovir disoproxil fumarate to tenofovir

PDF) Risk factors associated with hypophosphatemia in chronic

Long-term growth and bone development in children of HBV-infected

Incidence and predictors of retreatment in chronic hepatitis B